TSC Life's Fluido AirGuard System Receives FDA Clearance for Hypothermia Prevention

TSC Life has received FDA 510(k) clearance for its Fluido AirGuard System, a moderate to high flow blood and IV fluid warming solution designed to prevent hypothermia in clinical settings. The system addresses a critical need in emergency care, surgery, ICU, labor and delivery, and severe trauma cases where rapid administration of warm IV fluids or blood products is essential. Research indicates that two-thirds of trauma patients already suffer from mild hypothermia upon emergency room arrival, with just one unit of refrigerated blood or one liter of room temperature crystalloid capable of reducing mean body temperature by 0.45° F.

The Fluido AirGuard System combines rapid infusion capabilities with enhanced patient safety features, delivering flow rates up to 800 mL/min (48 L/hr) while addressing the significant risk of outgassing—the release of dissolved gasses when fluids are warmed. This phenomenon can form bubbles that enter the bloodstream and potentially cause serious complications such as stroke, heart attack, or death. The system features automatic air detection and IV-line clamping technology to prevent air bubbles from entering the patient's bloodstream, providing an additional layer of protection during high-flow infusions.

Chris Duffie, Commercial VP for the U.S., emphasized the system's clinical utility, stating that the technology combines high performance with ease of use and affordability. The removable warming cassette allows the system to move with patients throughout their clinical journey, while pressurized operation in under 20 seconds and streamlined controls ensure reliable care. The system's compliance with current safety standards promotes patient safety without compromising on performance or efficiency.

The FDA clearance comes as TSC Life transitions to a direct commercial presence in the U.S. market, having previously relied on Stryker for distribution of its Mistral-Air portfolio. CEO Paraic Curtis noted that establishing a direct commercial team has accelerated company expansion, strengthened customer relationships, and improved U.S. customer care while facilitating new product launches like the Fluido AirGuard System. This strategic shift supports TSC Life's broader commitment to developing intuitive medical devices that allow healthcare providers to focus more on patient care and less on equipment operation.